• Swahili (East Africa)
  • English (UK)
AI-REAL AI-REAL
  • Home
  • About the Study
  • Projects
    • CPI
    • SEREN
  • Team
  • Publications
  • News
  • Contact

Dr Sam M Mbulaiteye

Principal Investigators
10 February 2021

Dr Sam M Mbulaiteye

MBChB, MPhil, MMed

Dr. Mbulaiteye is a senior investigator (see here) in the Infections and Immunoepidemiology Branch (IIB) in the Division of Cancer Epidemiology and Genetics (DCEG) at the US National Cancer Institute (NCI). He conducts multidisciplinary epidemiological research to understand the role of infections, immunity, and genetic factors in the aetiology of cancer, particularly Burkitt lymphoma and Kaposi sarcoma.

To achieve these goals, Dr. Mbulaiteye designed and conducted a large multi-country, multiyear case-control study of endemic Burkitt lymphoma called Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM) study (https://emblem.cancer.gov/) in six rural regions in Uganda, Tanzania, and Kenya between 2010-2016. EMBLEM collected well annotated samples to facilitate research for the discovery of biomarkers that may be used for early detection, diagnosis, prognosis, or prevention of Burkitt lymphoma.

In addition, Dr. Mbulaiteye has established collaboration with the AI-REAL study as an investigator, a member of the Steering Committee, and as a mentor. He has provided full access to his collaborators at St. Mary’s Hospital Lacor in Uganda to the AI-REAL study and allowed full collaborative access to the EMBLEM facilities in Uganda.

  • Prev
  • Next
logo

Over 90% of children in the world with special types of blood cancers called lymphomas are from sub-Saharan Africa. This is because a virus called Epstein-Barr virus (EBV), malaria and HIV all contribute to causing these specific types of lymphomas. 

GET NEWSLETTERS

POPULAR POST

Professor Anna Schuh

Dr. med. Oliver Henke

Dr Elifuraha W Mkwizu

Dr Clara Chamba

Dr Sam M Mbulaiteye

Copyright 2021 AI-Real | All Rights Reserved

Follow us:

Joomla Template by ThemeXpert